ZOTEPINE |
ZOLEPTIL 25 |
ZOLEPTIL 100 |
ZOLEPTIL 50 |
ZOLEPTIL® |
2-CHLORO-11-(2-(DIMETHYLAMINO)ETHOXY)DIBENZO(B,F)THIEPIN |
drugbank:09225 |
chemidplus:26615-21-4 |
rxcui:40003 |
pubchem.compound:5736 |
chembl:CHEMBL285802 |
Drug Groups | approved |
Drug Groups | investigational |
Drug Groups | withdrawn |
Drug Type | small molecule |
Drug Categories | antidepressive agents |
Drug Categories | antipsychotic agents |
Drug Categories | antipsychotic agents (second generation [atypical]) |
Drug Categories | central nervous system agents |
Drug Categories | central nervous system depressants |
Drug Categories | cytochrome p-450 cyp1a2 substrates |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 substrates |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | dopamine antagonists |
Drug Categories | dopamine d2 receptor antagonists |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | nervous system |
Drug Categories | neurotoxic agents |
Drug Categories | psycholeptics |
Drug Categories | psychotropic drugs |
Drug Categories | serotonergic drugs shown to increase risk of serotonin syndrome |
Drug Categories | serotonin 5-ht2 receptor antagonists |
Drug Categories | serotonin agents |
Drug Categories | serotonin receptor antagonists |
Drug Categories | sulfur compounds |
Drug Categories | thiepins |
Drug Categories | tranquilizing agents |
antagonist (inhibitory) |
Specific Action of the Ligand | Inverse agonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Endogenous Drug? | False |
Specific Action of the Ligand | Inverse agonist |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | False |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | False |
antagonist (inhibitory) |
Endogenous Drug? | False |
Specific Action of the Ligand | Antagonist |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
Direct Interaction? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
Direct Interaction? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
Direct Interaction? | False |
antagonist (inhibitory) |
Direct Interaction? | False |
Endogenous Drug? | False |
Specific Action of the Ligand | Antagonist |
antagonist (inhibitory) |
Specific Action of the Ligand | Inverse agonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
ZOTEPINE | DrugBank Drug Name |
26615-21-4 | CAS Number |
Losizopilon | Drug Brand |
Drug Groups | approved |
Drug Groups | investigational |
Drug Groups | withdrawn |
ZOTEPINE | GuideToPharmacology Ligand Name |
D0T6QX | TTD Drug ID |